483
BAMF Health, Inc.FDA 483 - BAMF Health, Inc. - July 01, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of BAMF Health Inc. in Grand Rapids, MI, from June 27 to July 1, 2022, revealed a significant deficiency in production and process controls. The firm failed to ensure consistent production of PET drugs meeting quality standards, specifically citing inadequate environmental monitoring during aseptic manufacturing operations.
Open in Dashboard
ID · 11425191-a700-4013-8a30-4c0d38873555